Page last updated: 2024-12-06
2-sulfobenzoic acid cyclic anhydride
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 65729 |
| SCHEMBL ID | 111049 |
| MeSH ID | M0090617 |
Synonyms (51)
| Synonym |
|---|
| AC-18348 |
| 1,1-dioxobenzo[c]oxathiol-3-one |
| 2-sulfobenzoic acid cyclic anhydride |
| 2-sulfobenzoic anhydride |
| nsc49162 |
| nsc-49162 |
| nsc11208 |
| nsc-11208 |
| o-sulfobenzoic acid, cyclic anhydride |
| sulfobenzoic anhydride |
| 3h-2, 1,1-dioxide |
| o-sulfobenzoic acid anhydride |
| o-sulfobenzoic anhydride |
| 81-08-3 |
| sulfobenzoicanhydride |
| 1,1-dioxo-2,1$l^{6}-benzoxathiol-3-one |
| 3h-2,1-benzoxathiol-3-one, 1,1-dioxide (9ci) |
| 2-sulfobenzoic acid cyclic anhydride, technical grade, 90% |
| S-9350 |
| inchi=1/c7h4o4s/c8-7-5-3-1-2-4-6(5)12(9,10)11-7/h1-4 |
| benzoic acid,2-sulfo,anhydride |
| 3h-2,1-benzoxathiol-3-one 1,1-dioxide |
| AKOS000121535 |
| benzoic acid, 2-sulfo-, cyclic anhydride |
| unii-0swh68iq5w |
| 3h-2,1-benzoxathiol-3-one, 1,1-dioxide |
| nsc 11208 |
| einecs 201-322-6 |
| 2-sulphobenzoic anhydride |
| benzoic acid, o-sulfo-, cyclic anhydride |
| 0swh68iq5w , |
| FT-0613416 |
| 2,1-benzoxathiol-3-one-1,1-dioxide |
| 3h-benzo[c][1,2]oxathiol-3-one 1,1-dioxide |
| SCHEMBL111049 |
| 2-sulfobenzoic acid anhydride |
| o-sulfobenzoic acid cyclic anhydride |
| 2-sulfobenzoic acid cycloanhydride |
| J-610045 |
| 2-sulfobenzoicanhydride |
| DTXSID4038681 |
| mfcd00005879 |
| F0777-0781 |
| CS-0066044 |
| 1,1-dioxo-2,1lambda6-benzoxathiol-3-one |
| Q27037740 |
| BCP26935 |
| FS-4037 |
| D73341 |
| EN300-18015 |
| 3h-2,1lambda6-benzoxathiole-1,1,3-trione |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 21.67
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.67) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||